OliX PharmaceuticalsInc (226950) — Cash Flow Quality Index

Latest as of December 2025: -0.79x

OliX PharmaceuticalsInc (226950) has a Cash Flow Quality Index of -0.79x as of December 2025. Operating cash flow of ₩-12.16 Billion is below net income of ₩15.39 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of OliX PharmaceuticalsInc to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.79x

Operating CF / Net Income

Operating Cash Flow

₩-12.16 Billion

KRW

Net Income

₩15.39 Billion

KRW

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for OliX PharmaceuticalsInc (None–None)

Year-by-year earnings quality comparison for OliX PharmaceuticalsInc. For live market cap and the full company financial profile, see market value of OliX PharmaceuticalsInc.

Year	Quality Index	Operating CF (KRW)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.